Financials

  • Market Capitalization 3 B
  • Employee 239
  • Founded 2021
  • CEO N/A
  • Website www.alumis.com
  • Headquarter Delaware, United States
  • FIGI BBG01J7X4PN2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.41
Rapporto prezzo/fatturato
34.51

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1716
SLS
SELLAS Life Sciences Group, Inc. - Common Stock
15.21 USD+10.78%+12.09%+51.49%+680.00%3.07 B USD
1736
ZLAB
Zai Lab Limited - American Depositary Shares
26.82 USD+3.03%+2.17%+46.32%+0.49%3.01 B USD
1782
NRIX
Nurix Therapeutics, Inc. - Common stock
26.88 USD+0.64%-2.25%+10.71%+139.79%2.79 B USD
1801
ATAI
AtaiBeckley Inc. - Common Stock
7.35 USD-0.54%-1.34%+2.51%+86.08%2.73 B USD